Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04PYQ
|
||||
| Former ID |
DNC012020
|
||||
| Drug Name |
PIPEROXAN
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [533545] | ||
| Formula |
C14H19NO2
|
||||
| Canonical SMILES |
C1CCN(CC1)CC2COC3=CC=CC=C3O2
|
||||
| InChI |
1S/C14H19NO2/c1-4-8-15(9-5-1)10-12-11-16-13-6-2-3-7-14(13)17-12/h2-3,6-7,12H,1,4-5,8-11H2
|
||||
| InChIKey |
LYKMMUBOEFYJQG-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 59-39-2
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Alpha-2C adrenergic receptor | Target Info | Inhibitor | [533545] | |
| Alpha-2B adrenergic receptor | Target Info | Inhibitor | [533545] | ||
| Alpha-2A adrenergic receptor | Target Info | Inhibitor | [533545] | ||
| Reactome | Adrenoceptors | ||||
| Adrenaline signalling through Alpha-2 adrenergic receptor | |||||
| Adrenaline,noradrenaline inhibits insulin secretion | |||||
| G alpha (i) signalling events | |||||
| G alpha (z) signalling events | |||||
| Surfactant metabolismR-HSA-390696:Adrenoceptors | |||||
| G alpha (z) signalling eventsR-HSA-390696:Adrenoceptors | |||||
| Surfactant metabolism | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.